-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Asia Pacific Pharmaceutical (002370.SZ) issued an announcement. The company recently received the “Drug Supplement Application Approval Notice” for spironolactone tablets approved and issued by the State Drug Administration. The company's spironolactone tablets passed the consistent evaluation of the quality and efficacy of generic drugs. Spironolactone tablets are suitable for the prevention of edematous diseases, hypertension, primary hyperaldosteronism and hypokalemia.

Zhitongcaijing·07/31/2026 09:25:15
Listen to the news
Zhitong Finance App News, Asia Pacific Pharmaceutical (002370.SZ) issued an announcement. The company recently received the “Drug Supplement Application Approval Notice” for spironolactone tablets approved and issued by the State Drug Administration. The company's spironolactone tablets passed the consistent evaluation of the quality and efficacy of generic drugs. Spironolactone tablets are suitable for the prevention of edematous diseases, hypertension, primary hyperaldosteronism and hypokalemia.